Foslevodopa is a soluble prodrug of levodopa primarily used as a treatment to manage motor fluctuations in patients with advanced Parkinson’s disease. By serving as a precursor to dopamine, it enhances… Read more
Foslevodopa is a soluble prodrug of levodopa primarily used as a treatment to manage motor fluctuations in patients with advanced Parkinson’s disease. By serving as a precursor to dopamine, it enhances the delivery of levodopa and is typically administered in combination with the prodrug foscarbidopa to minimize peripheral side effects. This category provides essential analytical tools for pharmaceutical development and quality control, offering a range of high-quality Foslevodopa reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for accurate impurity profiling and method validation, enabling laboratories to ensure the precision and reliability of quantitative analytical testing throughout the drug substance lifecycle. Researchers utilize these characterized compounds to support comprehensive stability studies and regulatory compliance requirements in the development of levodopa-based therapeutic formulations.